Tao Hu, Hwang Suk-Won, Marelli Benedetto, An Bo, Moreau Jodie E, Yang Miaomiao, Brenckle Mark A, Kim Stanley, Kaplan David L, Rogers John A, Omenetto Fiorenzo G
Department of Biomedical Engineering, Tufts University, Medford, MA 02155;
Department of Materials Science and Engineering, Beckman Institute for Advanced Science and Technology, and Frederick Seitz Materials Research Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL 61801;
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17385-9. doi: 10.1073/pnas.1407743111. Epub 2014 Nov 24.
A paradigm shift for implantable medical devices lies at the confluence between regenerative medicine, where materials remodel and integrate in the biological milieu, and technology, through the use of recently developed material platforms based on biomaterials and bioresorbable technologies such as optics and electronics. The union of materials and technology in this context enables a class of biomedical devices that can be optically or electronically functional and yet harmlessly degrade once their use is complete. We present here a fully degradable, remotely controlled, implantable therapeutic device operating in vivo to counter a Staphylococcus aureus infection that disappears once its function is complete. This class of device provides fully resorbable packaging and electronics that can be turned on remotely, after implantation, to provide the necessary thermal therapy or trigger drug delivery. Such externally controllable, resorbable devices not only obviate the need for secondary surgeries and retrieval, but also have extended utility as therapeutic devices that can be left behind at a surgical or suturing site, following intervention, and can be externally controlled to allow for infection management by either thermal treatment or by remote triggering of drug release when there is retardation of antibiotic diffusion, deep infections are present, or when systemic antibiotic treatment alone is insufficient due to the emergence of antibiotic-resistant strains. After completion of function, the device is safely resorbed into the body, within a programmable period.
植入式医疗设备的范式转变存在于再生医学与技术的交汇点。在再生医学中,材料会在生物环境中重塑并整合;而技术方面,则是通过使用基于生物材料以及光电子学等生物可吸收技术的最新材料平台。在这种情况下,材料与技术的结合催生了一类生物医学设备,这类设备具有光学或电子功能,且在使用完毕后能无害地降解。我们在此展示一种完全可降解、可远程控制的植入式治疗设备,它在体内运行以对抗金黄色葡萄球菌感染,一旦其功能完成便会消失。这类设备提供完全可吸收的封装和电子元件,在植入后可远程开启,以提供必要的热疗或触发药物递送。这种外部可控的可吸收设备不仅消除了二次手术和取出的需求,而且作为治疗设备具有更广泛的用途,在干预后可留在手术或缝合部位,并可通过外部控制,在抗生素扩散受阻、存在深部感染或因抗生素耐药菌株出现而单独进行全身抗生素治疗不足时,通过热疗或远程触发药物释放来进行感染管理。功能完成后,该设备会在可编程的时间段内安全地被身体吸收。